Drug Kinetics – News and Features

Oregon State researchers discovered that exposing a copper-based MOF to ammonia gas doubles its CO2 adsorption ability. This method enhances carbon capture efficiency without increasing regeneration energy.

Researchers have developed programmable DNA nanostructures using DNA origami. These customizable nanobots have vast applications, from targeted drug delivery and adaptive materials to energy-efficient optical systems.

A tiny, four-fingered “hand” folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them.

A study reveals that gut bacteria impact tamoxifen’s effectiveness in breast cancer treatment. Certain bacterial enzymes enhance the drug's recycling into the bloodstream, improving its efficacy.

A Mount Sinai team has developed a blood-brain barrier-crossing conjugate (BCC) platform, enabling therapeutic molecules to target the brain. The system effectively silenced disease-related genes like Sod1 in ALS and Mapt in Alzheimer’s.

This article explores the difficulties faced in attempting to treat HIV, an innovative prevention strategy and the possibility of a cure.

Nanoparticles coated with polymers made with natural sugars could reduce the immune response to cancer treatment, making it more effective.

RNA therapeutics promise rapid, personalized and flexible treatments against multiple diseases. In this article, we will explore whether RNA therapeutics can realize their full potential.

In a groundbreaking new study, scientists have revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency.

Machine learning and supercomputer simulations have been used to investigate how tiny gold nanoparticles bind to blood proteins.